Ceretype Neuromedicine

Cambridge, MA

Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.

Company Details

Founded: 2020
Employees: Between 5 - 10 employees
Raised: $4,350,000
Headquarters Location: Cambridge, MA
Public: No
Acquired: No
CEO: Emily Stern
Founders: David Silbersweig
Hong Pan
Emily Stern

Company Collections

These are collections Ceretype Neuromedicine is a part of. Click on the collection name to view similar companies.

Ceretype Neuromedicine's Industries

Software Companies

Medical Organizations

Health Care Companies

Ceretype Neuromedicine's Tech Stack

Company Collections For Ceretype Neuromedicine

Has Woman Founder

Ceretype Neuromedicine Headquarters Location

1 Broadway 14th Floor, Cambridge, MA 02142

Total Amount Raised: $4,350,000

Ceretype Neuromedicine Funding Rounds

Pre Seed
$100,000
Mar 1, 2023
Pre Seed Investors
One Mind Accelerator
THE CATALYTIC IMPACT FOUNDATION (CIF)
Seed
$2,000,000
Jan 3, 2023
Seed Investors
Cedar Street Group
One Mind Accelerator
Leafy Tunnel
Seed
$2,250,000
Feb 1, 2022
Seed Investors
THE CATALYTIC IMPACT FOUNDATION (CIF)

Funding info provided by Diffbot.

Ceretype Neuromedicine Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ceretype Neuromedicine.